These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 3825692)

  • 1. Effects of tyrosine administration on plasma biopterin in patients with juvenile parkinsonism and their relatives.
    Kondo T; Narabayashi H; Nagatsu T; Yamaguchi T; Sawada M
    Adv Neurol; 1987; 45():217-22. PubMed ID: 3825692
    [No Abstract]   [Full Text] [Related]  

  • 2. CSF biopterin levels and clinical features of patients with juvenile parkinsonism.
    Furukawa Y; Nishi K; Kondo T; Mizuno Y; Narabayashi H
    Adv Neurol; 1993; 60():562-7. PubMed ID: 8420192
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of tyrosine administration on serum biopterin in normal controls and patients with Parkinson's disease.
    Yamaguchi T; Nagatsu T; Sugimoto T; Matsuura S; Kondo T; Iizuka R; Narabayashi H
    Science; 1983 Jan; 219(4580):75-7. PubMed ID: 6849120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A family with hereditary juvenile dystonia-parkinsonism.
    Ishikawa A; Miyatake T
    Mov Disord; 1995 Jul; 10(4):482-8. PubMed ID: 7565830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial juvenile Parkinsonism.
    Carlier G; Dubru JM
    Acta Paediatr Belg; 1979; 32(2):123-7. PubMed ID: 495089
    [No Abstract]   [Full Text] [Related]  

  • 6. Tyrosine hydroxylase cofactor (tetrahydrobiopterin) in parkinsonism.
    LeWitt PA; Miller LP; Newman RP; Burns RS; Insel T; Levine RA; Lovenberg W; Calne DB
    Adv Neurol; 1984; 40():459-62. PubMed ID: 6421110
    [No Abstract]   [Full Text] [Related]  

  • 7. [The relation between metabolism of biopterin and dystonia-parkinsonism].
    Ichinose H; Ohye T; Suzuki T; Inagaki H; Nagatsu T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Apr; 19(2):85-9. PubMed ID: 10464780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Catecholamine excretion in patients with parkinsonism and their relatives].
    Atadzhanov M; Tret'iakova KA; Shavolina VA
    Klin Med (Mosk); 1972 Sep; 50(9):48-51. PubMed ID: 4652970
    [No Abstract]   [Full Text] [Related]  

  • 9. A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation.
    Markopoulou K; Wszolek ZK; Pfeiffer RF
    Ann Neurol; 1995 Sep; 38(3):373-8. PubMed ID: 7668822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Familial aggregation in the occurrence of cases of parkinsonism].
    Otto FG
    Nervenarzt; 1983 Aug; 54(8):423-5. PubMed ID: 6621752
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of familial aggregation of Parkinson disease and Alzheimer disease.
    Levy G; Louis ED; Mejia-Santana H; Côté L; Andrews H; Harris J; Waters C; Ford B; Frucht S; Fahn S; Ottman R; Marder K
    Arch Neurol; 2004 Jul; 61(7):1033-9. PubMed ID: 15262733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial aggregation of Parkinson's disease: The Mayo Clinic family study.
    Rocca WA; McDonnell SK; Strain KJ; Bower JH; Ahlskog JE; Elbaz A; Schaid DJ; Maraganore DM
    Ann Neurol; 2004 Oct; 56(4):495-502. PubMed ID: 15455403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholamine-related enzymes and the biopterin cofactor in Parkinson's disease and related extrapyramidal diseases.
    Nagatsu T; Yamaguchi T; Rahman MK; Trocewicz J; Oka K; Hirata Y; Nagatsu I; Narabayashi H; Kondo T; Iizuka R
    Adv Neurol; 1984; 40():467-73. PubMed ID: 6141712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial parkinsonism and dementia with "ballooned neurons".
    Mizutani T; Inose T; Nakajima S; Gambetti P
    Adv Neurol; 1993; 60():613-7. PubMed ID: 8420199
    [No Abstract]   [Full Text] [Related]  

  • 15. Autosomal dominant Lewy body parkinsonism in a four-generation family.
    Waters CH; Miller CA
    Ann Neurol; 1994 Jan; 35(1):59-64. PubMed ID: 8285594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial parkinsonism.
    Rajasekhran Nair K; Bhaskaran R
    Acta Neurol (Napoli); 1986 Dec; 8(6):633-8. PubMed ID: 3825619
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial occurrence of amyotrophic lateral sclerosis, parkinsonism, and dementia.
    Schmitt HP; Emser W; Heimes C
    Ann Neurol; 1984 Dec; 16(6):642-8. PubMed ID: 6524873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exclusion of genetic linkage to 4q21-23 and 17q21 in a family with Lewy body parkinsonism.
    Hardy J; Pérez-Tur J; Baker M; Farrer M; Crook R; Hutton M; Johnson WG; Gwinn K; Muenter M; Rocca WA; Maraganore D
    Am J Med Genet; 1998 Mar; 81(2):166-71. PubMed ID: 9613857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of CSF biopterin and neopterin in hereditary progressive dystonia with marked diurnal fluctuation (HPD)--a clue to pathogenesis].
    Furukawa Y; Nishi K; Mizuno Y; Narabayashi H
    No To Shinkei; 1995 Mar; 47(3):261-8. PubMed ID: 7669428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic linkage studies in autosomal dominantly inherited L-DOPA responsive parkinsonism. Evaluation of candidate genes.
    Gasser T; Wszolek Z; Supala A; Trofatter J; Ozelius L; Uitti RJ; Pfeiffer RF; Gusella J; Calne D; Breakefield XO
    Adv Neurol; 1996; 69():87-95. PubMed ID: 8615189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.